topotecan has been researched along with ganglioside, gd2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gil, M; Horwacik, I; Kowalczyk, A; Kozbor, D; Odrowaz, Z; Rokita, H | 1 |
| Augustyniak, E; Boratyn, E; Drożniak, J; Durbas, M; Górka, A; Horwacik, I; Kowalczyk, A; Krzanik, S; Rokita, H; Sawicka, A; Węgrzyn, P | 1 |
2 other study(ies) available for topotecan and ganglioside, gd2
| Article | Year |
|---|---|
The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carboplatin; Cell Adhesion; Cell Line, Tumor; Doxorubicin; Drug Synergism; Flow Cytometry; Gangliosides; Humans; Immunotherapy; Microscopy, Fluorescence; Neuroblastoma; Topotecan | 2009 |
Analysis of genes involved in response to doxorubicin and a GD2 ganglioside-specific 14G2a monoclonal antibody in IMR-32 human neuroblastoma cells.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cell Line, Tumor; Cluster Analysis; Dose-Response Relationship, Drug; Doxorubicin; Gangliosides; Gene Expression Regulation, Neoplastic; Humans; Mice; Mitochondrial Proteins; Molecular Chaperones; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Oncogene Proteins; Software; Topotecan; Transcriptome | 2015 |